Martha Gulati/www.womenheart.org; Annalisa Filtz, Leandro Slipczuk/LinkedIn
Mar 21, 2026, 11:34
Martha Gulati: How Does Lp(a) Drive Atherosclerosis?
Martha Gulati, Director of the Davis Women Heart Center at Houston Methodist DeBakey Heart and Vascular Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“How does Lp(a) drive atherosclerosis?
- Delivers cholesterol to the arterial wall
- Carries oxidized phospholipids, leading to vascular inflammation
- Interferes with plasminogen, resulting in impaired fibrinolysis
- Promotes an atherothrombotic environment
Understanding these mechanisms strengthens the case for targeted Lp(a) therapies.”
Title: Presumed Mechanisms Underlying Lipoprotein(a)-caused Atherosclerosis
Authors: Annalisa Filtz, Leandro Slipczuk, Martha Gulati
Read the Full Article on ECR Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids